This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Mitsui Toatsu Chemicals, Incorporated, Mochida Pharmaceutical Co., Ltd., Schering Aktiengesellschaft. Active years: 2000-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1,379 
1 out of 229 
1 out of 1,409 Years Active: 2000-2003
Title: Masahiko Ishibashi: Innovator in Pharmaceutical Formulations
Introduction
Masahiko Ishibashi is a notable inventor based in Mobara, Japan. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of compositions that enhance the solubility and efficacy of therapeutic agents. With a total of 2 patents to his name, Ishibashi's work has the potential to impact clinical practices significantly.
Latest Patents
Ishibashi's latest patents include a benzamide formulation with histone deacetylase inhibitor activity. Additionally, he has developed a method for improving the solubility of tissue plasminogen activator. This thrombolytic composition contains tissue-type plasminogen activator or a derivative, combined with an anionic polymer or a salt thereof, and an amine compound or a salt thereof. The composition can be prepared as an aqueous solution or a lyophilized preparation, which remains stably dissolved upon dilution at near-neutral pH in both high and low salt concentration pharmaceutical solutions. These innovations are designed for clinically useful products intended for infusion or injection at a pH close to neutral.
Career Highlights
Throughout his career, Ishibashi has worked with prominent companies such as Schering Aktiengesellschaft and Mitsui Toatsu Chemicals, Incorporated. His experience in these organizations has allowed him to refine his expertise in pharmaceutical development and innovation.
Collaborations
Ishibashi has collaborated with notable colleagues, including Masahiro Sakabe and Ikuo Sakai. These partnerships have contributed to the advancement of his research and the successful development of his patented formulations.
Conclusion
Masahiko Ishibashi's contributions to pharmaceutical innovations demonstrate his commitment to improving therapeutic solutions. His patents reflect a deep understanding of the complexities involved in drug formulation, paving the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile